Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09415-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Giovanni Pagano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, Federico II Naples University, via Cintia, Naples, I-80126, Italy. paganog756@gmail.com. Hauptthemen laut MEDLINE: Fragile X Syndrome, Mitochondrial Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Napoli Federico II.
Abstract (Originalsprache)
Fragile X syndrome (FXS) is a genetic disorder characterized by mutation in the FMR1 gene, leading to the absence or reduced levels of fragile X Messenger Ribonucleoprotein 1 (FMRP). This results in neurodevelopmental deficits, including autistic spectrum conditions. On the other hand, Fragile X-associated tremor/ataxia syndrome (FXTAS) is a distinct disorder caused by the premutation in the FMR1 gene. FXTAS is associated with elevated levels of FMR1 mRNA, leading to neurodegenerative manifestations such as tremors and ataxia. Mounting evidence suggests a link between both syndromes and mitochondrial dysfunction (MDF). In this minireview, we critically examine the intricate relationship between FXS, FXTAS, and MDF, focusing on potential therapeutic avenues to counteract or mitigate their adverse effects. Specifically, we explore the role of mitochondrial cofactors and antioxidants, with a particular emphasis on alpha-lipoic acid (ALA), carnitine (CARN) and Coenzyme Q10 (CoQ10). Findings from this review will contribute to a deeper understanding of these disorders and foster novel therapeutic strategies to enhance patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, Federico II Naples University, via Cintia, Naples, I-80126, Italy. paganog756@gmail.com.
- Sabanci University, Tuzla, Istanbul, 34956, Turkey.
- Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia-INCLIVA, CIBERER, Valencia, E-46010, Spain.
- Department of Life and Environmental Sciences, Polytechnical University of Marche, Ancona, I-60121, Italy.
- Department of Genetics, ASL Napoli 1, Naples, I-80144, Italy.
- Department of Chemical Sciences, Federico II Naples University, via Cintia, Naples, I-80126, Italy.
Förderung
- Università degli Studi di Napoli Federico II
Zitieren
APA
Pagano, G., Lyakhovich, A., Pallardó, F. V., Tiano, L., Zatterale, A., & Trifuoggi, M. (2024). Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09415-7
Vancouver
Pagano G, Lyakhovich A, Pallardó FV, Tiano L, Zatterale A, Trifuoggi M. Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09415-7
BibTeX
@article{Pagano2024,
author = {Pagano, Giovanni and Lyakhovich, Alex and Pallardó, Federico V and Tiano, Luca and Zatterale, Adriana and Trifuoggi, Marco},
title = {Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09415-7}
}
EUVIMED